Mark Drew, PhD
Dr. Drew, PhD, completed his doctorate degree in synthetic organic chemistry from the University of Manchester Institute of Science and Technology, UK. He completed postdoctoral research in asymmetric synthesis at IUPUI, Indiana, USA. From 2000, he has been a Medicinal Chemist/Lead Research Scientist at Array BioPharma, Sanofi Pharmaceuticals and Icagen, Inc. working on discovery and optimization projects for oncology, inflammatory and rare disease indications. Dr. Drew was the translation Project Manager to the Center for Innovation in Brain Science, University of Arizona from 2020-2023, working on clinical-stage therapeutics for age-related neurodegeneration. Dr. Drew is a USPTO licensed patent agent and holds a current Project Management Professional Certification.